OOIR: Observatory of International Research

Papers

(The TQCC of International Clinical Psychopharmacology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	37
The role of personality traits in following quarantine orders during the COVID-19 pandemic	27
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	24
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	17
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	16
Antidepressant psychopharmacology: is inflammation a future target?	16
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	15
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	13
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	12
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	12
Clinical specificity profile for novel rapid acting antidepressant drugs	12
Open issues in bipolar and antipsychotic treatments	11
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	10
Doxazosin improved COVID-19 associated nightmare in a patient with major depressive disorder: a case report with a positive rechallenge	10
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	10
Managing depression in the elderly: real-world clinical considerations and perspectives	10
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition	10
Case series on aripiprazole and dopamine supersensitivity psychosis	10
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration	10
Debated issues in major psychoses	9
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder	9
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder	9
Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison	9
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	9
The Gordian knot of the immune-redox systems’ interactions in psychosis	9

Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia	9
Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders	8
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials	8
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review	8
Elevated liver transaminases among patients with psychiatric disorders	8
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?	8
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	7
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis	7
Case report and systematic review of cerebellar vermis alterations in psychosis	7
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	7
Modulating factors in mood disorders treatment	7
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial	7
Innovation in psychopharmacology	7
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	7
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	6
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	6
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	6
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	6
Allergic reaction induced by subcutaneous administration of ketamine: a case report	6
Interplay of environmental and clinical factors in psychiatric disorders	6
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	6
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	6
Manic episode in a patient with pancreatic adenocarcinoma: a case report	5
Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland	5
The challenge of managing difficult to treat psychiatric conditions	5
Advances in the treatment of depression	5
Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: a prospective naturalistic study	5
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	5
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	5
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	5
The potential use of daridorexant in eating disorders: beyond the treatment of insomnia?	4
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience	4
Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms	4
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students	4
Pharmacological and philosophical considerations for the around-the-clock use of scheduled melatonin to promote sedation and reduce aggression in individuals with serious mental illness: a case report	4
Impact of long-acting injectable aripiprazole on the concomitant medication and antipsychotic polypharmacy: a retrospective, observational study of 127 patients with psychosis	4
Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation	4
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?	4
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features	4
QT prolongation is over-estimated by Bazett compared to Friderica in Japanese child and adolescent inpatients	4
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences	4
The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial	4
Persian translation and validation of community attitudes toward the mentally ill scale: a tool for assessing social stigma about mental illness	4